Impact of a combined intravenous/intra-arterial approach in octogenarians

Mikael Mazighi, Julien Labreuche, Elena Meseguer, Jean Michel Serfaty, Jean Pierre Laissy, Philippa C. Lavallée, Lucie Cabrejo, Céline Guidoux, Bertrand Lapergue, Isabelle F. Klein, Jean Marc Olivot, Halim Abboud, Olivier Simon, Elisabeth Schouman-Claeys, Pierre Amarenco

Research output: Contribution to journalArticle

Abstract

Background: Intravenous (IV) alteplase is not currently recommended in octogenarian patients, and the benefit/risk ratio of endovascular (intra-arterial, IA) therapy remains to be determined. The aim of this study was to determine the impact of a combined IV-IA approach in octogenarians. Methods: From a single-centre interventional study, we report age-specific outcomes of patients treated by a combined IV-IA thrombolytic approach. Patients ≥80 years with documented arterial occlusion treated by conventional IV thrombolysis constituted the control group. Results: Among 84 patients treated by the IV-IA approach, those ≥80 years (n = 25) had a similar rate of early neurological improvement to that of patients

Original languageEnglish (US)
Pages (from-to)559-565
Number of pages7
JournalCerebrovascular Diseases
Volume31
Issue number6
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Odds Ratio
Control Groups
Therapeutics

Keywords

  • Alteplase
  • Combined intravenous/intra-arterial approach
  • Octogenarians
  • Recombinant tissue plasminogen activator

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Mazighi, M., Labreuche, J., Meseguer, E., Serfaty, J. M., Laissy, J. P., Lavallée, P. C., ... Amarenco, P. (2011). Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovascular Diseases, 31(6), 559-565. https://doi.org/10.1159/000324626

Impact of a combined intravenous/intra-arterial approach in octogenarians. / Mazighi, Mikael; Labreuche, Julien; Meseguer, Elena; Serfaty, Jean Michel; Laissy, Jean Pierre; Lavallée, Philippa C.; Cabrejo, Lucie; Guidoux, Céline; Lapergue, Bertrand; Klein, Isabelle F.; Olivot, Jean Marc; Abboud, Halim; Simon, Olivier; Schouman-Claeys, Elisabeth; Amarenco, Pierre.

In: Cerebrovascular Diseases, Vol. 31, No. 6, 05.2011, p. 559-565.

Research output: Contribution to journalArticle

Mazighi, M, Labreuche, J, Meseguer, E, Serfaty, JM, Laissy, JP, Lavallée, PC, Cabrejo, L, Guidoux, C, Lapergue, B, Klein, IF, Olivot, JM, Abboud, H, Simon, O, Schouman-Claeys, E & Amarenco, P 2011, 'Impact of a combined intravenous/intra-arterial approach in octogenarians', Cerebrovascular Diseases, vol. 31, no. 6, pp. 559-565. https://doi.org/10.1159/000324626
Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, Lavallée PC et al. Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovascular Diseases. 2011 May;31(6):559-565. https://doi.org/10.1159/000324626
Mazighi, Mikael ; Labreuche, Julien ; Meseguer, Elena ; Serfaty, Jean Michel ; Laissy, Jean Pierre ; Lavallée, Philippa C. ; Cabrejo, Lucie ; Guidoux, Céline ; Lapergue, Bertrand ; Klein, Isabelle F. ; Olivot, Jean Marc ; Abboud, Halim ; Simon, Olivier ; Schouman-Claeys, Elisabeth ; Amarenco, Pierre. / Impact of a combined intravenous/intra-arterial approach in octogenarians. In: Cerebrovascular Diseases. 2011 ; Vol. 31, No. 6. pp. 559-565.
@article{f1cce313054b488cb5b6f2bef377ff89,
title = "Impact of a combined intravenous/intra-arterial approach in octogenarians",
abstract = "Background: Intravenous (IV) alteplase is not currently recommended in octogenarian patients, and the benefit/risk ratio of endovascular (intra-arterial, IA) therapy remains to be determined. The aim of this study was to determine the impact of a combined IV-IA approach in octogenarians. Methods: From a single-centre interventional study, we report age-specific outcomes of patients treated by a combined IV-IA thrombolytic approach. Patients ≥80 years with documented arterial occlusion treated by conventional IV thrombolysis constituted the control group. Results: Among 84 patients treated by the IV-IA approach, those ≥80 years (n = 25) had a similar rate of early neurological improvement to that of patients",
keywords = "Alteplase, Combined intravenous/intra-arterial approach, Octogenarians, Recombinant tissue plasminogen activator",
author = "Mikael Mazighi and Julien Labreuche and Elena Meseguer and Serfaty, {Jean Michel} and Laissy, {Jean Pierre} and Lavall{\'e}e, {Philippa C.} and Lucie Cabrejo and C{\'e}line Guidoux and Bertrand Lapergue and Klein, {Isabelle F.} and Olivot, {Jean Marc} and Halim Abboud and Olivier Simon and Elisabeth Schouman-Claeys and Pierre Amarenco",
year = "2011",
month = "5",
doi = "10.1159/000324626",
language = "English (US)",
volume = "31",
pages = "559--565",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Impact of a combined intravenous/intra-arterial approach in octogenarians

AU - Mazighi, Mikael

AU - Labreuche, Julien

AU - Meseguer, Elena

AU - Serfaty, Jean Michel

AU - Laissy, Jean Pierre

AU - Lavallée, Philippa C.

AU - Cabrejo, Lucie

AU - Guidoux, Céline

AU - Lapergue, Bertrand

AU - Klein, Isabelle F.

AU - Olivot, Jean Marc

AU - Abboud, Halim

AU - Simon, Olivier

AU - Schouman-Claeys, Elisabeth

AU - Amarenco, Pierre

PY - 2011/5

Y1 - 2011/5

N2 - Background: Intravenous (IV) alteplase is not currently recommended in octogenarian patients, and the benefit/risk ratio of endovascular (intra-arterial, IA) therapy remains to be determined. The aim of this study was to determine the impact of a combined IV-IA approach in octogenarians. Methods: From a single-centre interventional study, we report age-specific outcomes of patients treated by a combined IV-IA thrombolytic approach. Patients ≥80 years with documented arterial occlusion treated by conventional IV thrombolysis constituted the control group. Results: Among 84 patients treated by the IV-IA approach, those ≥80 years (n = 25) had a similar rate of early neurological improvement to that of patients

AB - Background: Intravenous (IV) alteplase is not currently recommended in octogenarian patients, and the benefit/risk ratio of endovascular (intra-arterial, IA) therapy remains to be determined. The aim of this study was to determine the impact of a combined IV-IA approach in octogenarians. Methods: From a single-centre interventional study, we report age-specific outcomes of patients treated by a combined IV-IA thrombolytic approach. Patients ≥80 years with documented arterial occlusion treated by conventional IV thrombolysis constituted the control group. Results: Among 84 patients treated by the IV-IA approach, those ≥80 years (n = 25) had a similar rate of early neurological improvement to that of patients

KW - Alteplase

KW - Combined intravenous/intra-arterial approach

KW - Octogenarians

KW - Recombinant tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=79953802887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953802887&partnerID=8YFLogxK

U2 - 10.1159/000324626

DO - 10.1159/000324626

M3 - Article

C2 - 21487220

AN - SCOPUS:79953802887

VL - 31

SP - 559

EP - 565

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 6

ER -